Published in

American Academy of Neurology (AAN), Neurology, 10(81), p. 865-871

DOI: 10.1212/wnl.0b013e3182a351fb

Links

Tools

Export citation

Search in Google Scholar

L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients

Journal article published in 2013 by Nicholas Schwab, Tilman Schneider-Hohendorf, Vilmos Posevitz, Johanna Breuer, Kerstin Goebel, K. Gobel, Kerstin Göbel, Susanne Windhagen, Bruno Brochet, Patrick Vermersch, Christine Lebrun-Frenay, Anita Posevitz-Fejfar, Ruggero Capra, Luisa Imberti, Vera Straeten and other authors.
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO